Biotech | March 16, 2026
The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission
The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days
Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains
The early-stage study will test the drug’s safety, tolerability and biological effects in humans
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
The conflict is also triggering a widening public health emergency
Remidex manufactures micronutrient premixes and nutraceuticals,
This inspection is now closed
Nearly 12 million people are estimated to be living with glaucoma, making the country one of the worst affected globally
Subscribe To Our Newsletter & Stay Updated
